Clinical Trial Update: Sleep Apnea, Arrhythmias and Cardiac Reverse Remodeling in Heart Failure Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating sleep apnea, arrhythmias, and cardiac reverse remodeling in heart failure patients sponsored by LivaNova has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrhythmia
• Heart Failure
• Sleep Apnea

Snippet

Sponsor: LivaNova | Conditions: Sleep Breathing Disorders in the Responders to Cardiac Resynchronisation Therapy (CRT) | Phase 4 | Status: WITHDRAWN